Association between fingertip-measured advanced glycation end products and cardiovascular events in outpatients with cardiovascular disease.

BACKGROUND: The accumulation of advanced glycation end products (AGEs) is associated with cardiovascular events in patients with cardiovascular disease (CVD). However, the relationship between the AGEs measured by an AGEs sensor noninvasively at the fingertip and prognosis in patients with CVD remains unclear. Therefore, this study aimed to determine the relationship between AGEs score and prognosis among patients with CVD. METHODS: A total of 191 outpatients with CVD were included. AGEs score were measured using an AGEs sensor and the patients were classified into groups by the median value of AGEs score. The incidence of major adverse cardiovascular and cerebrovascular events (MACCE) at 30 months was compared between high- and low-AGEs score groups. In addition, receiver operating characteristic (ROC) curve analysis was used to calculate cutoff value for the AGEs score, which discriminates the occurrence of MACCE. Cox regression analysis was performed to identify the factors associated with the presence of MACCE. MACCE included cardiac death, myocardial infarction, percutaneous coronary intervention, heart failure, and stroke. RESULTS: AGEs score was normally distributed, with a median value of 0.51. No significant intergroup differences were found in laboratory findings, physical functions, or medications. The high-AGEs score group had a significantly higher incidence of MACCE than the low-AGEs score group (27.1 vs. 10.5%, P = 0.007). A high-AGEs score was a risk factor for MACCE (hazard ratio, 2.638; 95% confidence interval, 1.271-5.471; P = 0.009). After the adjustment for confounders other than 6-min walking distance, the AGEs score remained a factor associated with the occurrence of MACCE. The best cutoff AGEs score for the detection of MACCE was 0.51 (area under the curve, 0.642; P = 0.008; sensitivity, 72.2%; specificity, 54.8%). CONCLUSIONS: AGEs score measured at the fingertip in patients with CVD is associated with MACCE. AGEs score, which can be measured noninvasively and easily, may be useful as an assessment for the secondary prevention of CVD in patients with CVD.

Effects of Alfaxalone on the Induction and Maintenance of Total Intravenous Anesthesia in Gentoo Penguins (Pygoscelis papua).

Systemic anesthesia in penguins is often achieved using inhalation anesthetic agents alone, and information on injectable drugs for systemic anesthesia is limited. General anesthesia with a minimal effect on circulatory dynamics is necessary to perform noninvasive examinations and treatments in animals, including penguins. In this study, alfaxalone (ALFX), an injectable anesthetic agent, was examined to establish the optimal anesthetic method for gentoo penguins (Pygoscelis papua). Alfaxalone was administered intravenously through the metatarsal vein, and anesthesia was maintained by a constant rate infusion (CRI). A biological monitor was used to record numerous clinical indices, and the anesthetic depth was evaluated every 5 minutes during anesthesia; the CRI was adjusted until the optimal anesthetic depth was obtained. Anesthesia depth was assessed, and the CRI rate was adjusted. The CRI was stopped, and the time until recovery was recorded. Blood samples were collected to analyze plasma concentrations of ALFX. The mean total dose of ALFX required for anesthetic induction was 9 ± 1.9 mg/kg, the intubation time was 126 ± 21 seconds, and the maintenance infusion rate of ALFX was 0.3 ± 0.08 mg/kg/min. The time from discontinuation of anesthesia to extubation was 42 ± 23 minutes, and the time to recovery was 90 ± 33 minutes. Significant changes in the heart rate and blood pressure were not observed during the anesthetic events. The plasma concentration of ALFX under stable anesthesia was 6734 ± 4386 ng/mL (range, 3315-14 326 ng/mL). Although anesthesia using ALFX tended to result in a prolonged time to recovery in gentoo penguins, rapid induction of anesthesia and stable hemodynamics during anesthetic maintenance were achieved. Therefore, ALFX may be considered a suitable anesthetic method for noninvasive examinations and treatments in penguins.

Ultrasonographic assessment of the internal jugular vein for the estimation of central venous pressure in hemodialysis patients: A preliminary study.

PURPOSE: To investigate a new noninvasive method to assess central venous pressure (CVP) in hemodialysis patients, based on the ultrasonographic measurement of the collapsing point of the internal jugular vein (CVPni). MATERIALS AND METHODS: In this preliminary, noninterventional, single center study, we enrolled 22 dialyzed patients with an indwelling jugular catheter. CVPni was compared to the gold-standard invasive measurement of CVP using the central venous catheter (CVPi). Agreement between CVPi and CVPni was assessed by Bland and Altman Method. Correlation was assessed by linear regression. RESULTS: A strong correlation was observed between CVPi and CVPni (OR = 3.47 [2.96; 4.07], P < .0001). For overloaded patients, the area under the curve for the operating characteristic curve was 0.971 (IC95: 0.915; 1.000). For under-loaded patients, area under the curve was 0.971 (IC95: 0.917; 1.000). The mean bias between intra-individual CVPi and CVPni measures was 0.57 cm H2 O (SD: 3.1 cm H2 O). CONCLUSION: CVPni appears as a noninvasive and reliable technique. Further studies are required to confirm these results and to assess the direct clinical impact of this new method.

Nomogram for the Prediction of High-Grade Dysplasia and Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas Based on Variables of Noninvasive Examination.

Intraductal papillary mucinous neoplasms (IPMNs) are a heterogeneous group of neoplasms and represent the most common identifiable precursor lesions of pancreatic cancer. Clinical decision-making of the risk for malignant disease, including high-grade dysplasia and invasive carcinoma, is challenging. Moreover, discordance on the indication for resection exists between the contemporary guidelines. Furthermore, most of the current nomogram models for predicting malignant disease depend on endoscopic ultrasonography to evaluate the precise size of mural nodules. Thus, this study aimed to propose a model to predict malignant disease using variables from a noninvasive examination. We evaluated patients who underwent resection of pathologically confirmed IPMNs between November 2010 and December 2018 and had preoperative clinical data available for review. Based on binary multivariable logistic regression analysis, we devised a nomogram model to predict malignant IPMNs. The area under the receiver operating characteristics curve (AUC) was used to evaluate the discrimination power of the model. Of the 333 patients who underwent resection of IPMNs, 198 (59.5%) had benign and 135 (40.5%) had malignant IPMNs. Multivariable logistic regression analysis showed that cyst size, cyst location, cyst wall enhancement, multicystic lesion, diameter of main pancreatic duct, neutrophil-to-lymphocyte ratio, serum carbohydrate antigen 19-9, and carcinoembryonic antigen were significantly associated with malignancy. The nomogram, constructed based on these variables, showed excellent discrimination power with an AUC of 0.859 (95% CI: 0.818-0.900, P < 0.001). In conclusion, we have developed a nomogram consisting of a combination of cross-sectional imaging features and blood markers, variables that can readily be obtained by noninvasive examinations during the surveillance period, which can distinguish benign from malignant IPMNs. Nevertheless, external validation is warranted.

Examining and monitoring paretic muscle changes during stroke rehabilitation using surface electromyography: A pilot study.

Complex neuromuscular changes have been reported to occur in paretic muscles following stroke, but whether and how they can recover under rehabilitation therapy remain unclear. A tracking analysis protocol needs to be designed involving multiple sessions of surface electromyography (sEMG) examinations during the rehabilitation procedure. Following such a protocol, this pilot study is aimed to monitor paretic muscle changes using three sEMG indicators namely clustering index (CI), root mean square (RMS) and medium frequency (MDF). Initially, a single sEMG examination was performed on the abductor pollicis brevis (APB) muscle on both sides of 23 subjects with stroke and one side of 18 healthy control subjects. With these data to establish CI diagnostic criterion, the paretic muscles of all subjects with stroke showed a very board CI distribution pattern from abnormally low values through normality to abnormally high values. Afterwards, 9 out of 23 subjects with stroke had their paretic muscles examined at least twice before and after the treatment. Almost all paretic muscles had an increase of the RMS, a change of the MDF approaching to the value of the contralateral muscle, and a change of the CI returning to its normal range after common rehabilitation treatments. Finally, 4 of the 9 subjects with stroke participated into repeated examinations of their paretic muscles. The combined use of three indicators helped to reveal specific neuromuscular processes contributing to recovery of paretic muscles, due to their complementary diagnostic powers. Furthermore, neuromuscular processes were found to vary across subjects in type, order and timing during rehabilitation. In conclusion, given the 4 cases following the tracking analysis protocol, this pilot study preliminarily demonstrates usability of three sEMG indicators as tools for examining and monitoring stroke rehabilitation procedure in terms of improvements of paretic muscle changes. All the revealed complex neuromuscular processes imply the necessity of applying sEMG examinations in monitoring rehabilitation procedure, with the potential of offering important guidelines for designing better and individualized protocols toward improved stroke rehabilitation.

Relationship between hepatic histopathological progression and findings of clinical noninvasive examination in patients with non-viral liver diseases / 第二军医大学学报

Objective To elucidate the relationship between hepatic histopathologic progression and findings of clinical noninvasive examination in patients with non-viral liver diseases. Methods A total of 222patients withnon-viral liver diseases, who received liver biopsy in our hospital, were included in the present study. The association of different histopathological progression (grade of hepatic inflammation and stage of fibrosis) with the noninvasive examination parameters (serum biochemical indicators and imaging findings) was investigated. Results We found that age, serum biochemical indicators, platelet(PLT), and ratios of aspartate aminotransferase to platelet (AST/PLT), aspartate aminotransferase to alanine aminotransferase (AST/ALT) and albumin to globulin (A/G) were significantly associated with the histopathological grades and stages of hepatictissues. The grades of inflammation were markedly different between 2 groups with ALT levels higher or lower than 1 upper limits of normal (ULN)(P=0.009); the stages of hepaticfibrosis were significantly different between 2 groups with ALT levels higher or lower than 2 ULN (P=0.030).The result of B-type ultrasonic examination was positively related to the grade of hepatic inflammation and stage of fibrosis(r=0.417,P=0.000;r=0.530,P=0.000). AST/PLT and prothrombin time (PT) levelwer significantly different between patients with hepatic fibrosis and those without(P=0.015, P=0.000); AST/ALT, AST/PLT, A/G and PT levels were also significantly different between cirrhotic patients and non cirrhotic cones (P=0.042,0.012,0.000, and 0.003, respectively). The area under ROC curve of non invasive analysis model APRI was the largest one among the 3 models. APRI model had the highest sensitivity in diagnosing liver fibrosis, but with a poor specificity; S-Index had a higher specificity but a poor sensitivity. Conclusion Clinical noninvasive parameters are valuable for evaluating the activity of Hepatic inflammation and stage of fibrosis in patients with non-viral liver diseases. Noninvasive analysis model is useful for diagnosing liver fibrosis and early cirrhosis.